glp 1 drug GLP-1 Agonists: A Comprehensive Overview Do The Benefits of GLP-1

What works for constipation may worsen bloating

Potential implications of the new pharmacotherapies on obesity management The mean WL in clinical trials with the most efficacious new obesity pharmacotherapies ranges between 15% and 25% at 1 year (and it may be even higher for some agents that have not reached weight plateau at study completion)

The July 2024 Harvard study from Massachusetts Eye and Ear found that individuals prescribed Ozempic and other GLP-1 drugs were at a heightened risk for developing NAION

Anti-obesity semaglutide drugs were originally developed to treat Type 2 diabetes, a metabolic disorder

In addition, an increase in glycaemic variability has been linked to adverse outcomes in CVD in an Asian population